Tag: heart disease

The Endocrine Society’s annual meeting, ENDO 2026, concluded its residency at Chicago’s McCormick Place this past June, marking a pivotal moment in the evolution of endocrine science and clinical practice. As the global medical community sifts through the wealth of data and insights presented during the conference, the event is being recognized not merely for…

The ENDO 2026 annual meeting, held this past June in Chicago, established itself as a landmark event for the global endocrine community, drawing record-breaking attendance during a period of profound transition for the healthcare sector. Despite a climate of economic uncertainty and fluctuating research budgets that have historically hampered long-term scientific inquiry, the field of…

New clinical research presented at the ENDO 2026 annual meeting suggests that glucagon-like peptide-1 (GLP-1) receptor agonists may offer a dual benefit for men, significantly improving both testosterone levels and sperm quality in those suffering from obesity-related hypogonadism. The study, led by Pratibha Natesh, MBBS, MRCP, MRes, an endocrinologist at University Hospitals Coventry and Warwickshire…

The Endocrine Society and Keystone Symposia have announced a landmark partnership to launch a specialized series of scientific meetings aimed at exploring the critical intersections of hormone signaling, oncology, diabetes, and cardiometabolic health. This collaboration represents a significant shift toward interdisciplinary research, seeking to break down traditional silos that have historically separated endocrinology from other…

New research published in the Journal of the Endocrine Society suggests that phthalates—a class of synthetic chemicals ubiquitous in modern consumer goods—may play a significant role in the development of high blood pressure among pregnant women. The study, led by researchers at the Harvard T.H. Chan School of Public Health, highlights a concerning link between…

The medical community is facing a growing challenge as new research reveals that at least one in 12 weight-loss surgery patients develops a severe, recurring low blood sugar condition that necessitates medical intervention. This finding, presented at the prestigious ENDO 2026 conference, highlights a significant and often overlooked complication of bariatric procedures known as post-bariatric…

The annual meeting of the Endocrine Society, known as ENDO 2026, recently served as the backdrop for one of the most high-stakes and fast-paced academic competitions in the field of hormone research: the Rising Star Power Talks. This year, the spotlight shone brightly on Brittany Weisbrot, an internal medicine resident at Loyola University Medical Center…

The field of endocrinology witnessed a significant convergence of academic rigor and rapid-fire communication at ENDO 2026 in Chicago, where the annual Rising Star Power Talks provided a high-stakes platform for the next generation of scientific leaders. Among the standout contributors was Dillon Boulton, PhD, a postdoctoral fellow from the University of Colorado Anschutz Medical…

A comprehensive retrospective study led by researchers at the University of Michigan has revealed a stark disconnect between established clinical guidelines and the actual prescribing practices for testosterone therapy in men. Presented as part of the ENDO 2026 research initiatives, the study conducted by Sophia Sinha, MD, and senior author Maria Papaleontiou, MD, found that…

Recent clinical findings presented at the ENDO 2026 annual meeting have provided compelling evidence that menopausal hormone therapy (MHT) plays a pivotal role in protecting skeletal integrity in postmenopausal women. The research, spearheaded by Diego Espinoza-Peralta, MD, MSc, indicates that women utilizing MHT face a substantially lower risk of developing low bone mineral density (BMD),…